Nadia Naldi
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 8
-
- Lung Cancer Treatments and Mutations 10
- Lung Cancer Diagnosis and Treatment 1
- Co-authors
- Roberta Camisa (14 shared papers)Andrea Ardizzoni (16 shared papers)Beatrice Bortesi (15 shared papers)Antonino Musolino (9 shared papers)Tauro Maria Neri (7 shared papers)Marzia Capelletti (5 shared papers)Debora Pezzuolo (2 shared papers)Giancarlo Bisagni (3 shared papers)
- Journals
- Cancer (5 papers)Diagnostic Cytopathology (4 papers)Lung Cancer (3 papers)Annals of Oncology (3 papers)The International Journal of Biological Markers (2 papers)
- Partner nations
- ItalyNew ZealandGermany
In The Last Decade
Nadia Naldi
45 papers receiving 1.9k citations
Nadia Naldi's Hit Papers
Peers
Comparison fields: 5 of 44
- Oncology 408
- Cancer Research 136
- Radiology, Nuclear Medicine and Imaging 228
- Genetics 262
- Pulmonary and Respiratory Medicine 251
Countries citing papers authored by Nadia Naldi
This map shows the geographic impact of Nadia Naldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Naldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Naldi more than expected).
Fields of papers citing papers by Nadia Naldi
This network shows the impact of papers produced by Nadia Naldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Naldi. The network helps show where Nadia Naldi may publish in the future.
Co-authors
The 25 scholars most cited alongside Nadia Naldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer Hit paper breakdown → | 2008 | 830 |
| 2 | 2019 | 121 | |
| 3 | 2007 | 114 | |
| 4 | 2017 | 73 | |
| 5 | 2013 | 68 | |
| 6 | 2016 | 64 | |
| 7 | 2005 | 62 | |
| 8 | 2002 | 52 | |
| 9 | 2000 | 46 | |
| 10 | 2015 | 44 | |
| 11 | 2003 | 39 | |
| 12 | 2003 | 32 | |
| 13 | 1995 | 31 | |
| 14 | 1994 | 26 | |
| 15 | 2018 | 26 | |
| 16 | 2016 | 25 | |
| 17 | 2005 | 24 | |
| 18 | 2012 | 24 | |
| 19 | 2019 | 24 | |
| 20 | Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients. | 1995 | 20 |
About Nadia Naldi
Nadia Naldi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Physiology, having authored 45 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), HER2/EGFR in Cancer Research (8 papers), BRCA gene mutations in cancer (7 papers), Breast Cancer Treatment Studies (5 papers), Clinical Laboratory Practices and Quality Control (2 papers), Breast Lesions and Carcinomas (1 paper), Lung Cancer Diagnosis and Treatment (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (408 citations), Cancer Research (136 citations), Radiology, Nuclear Medicine and Imaging (228 citations), Genetics (262 citations) and Pulmonary and Respiratory Medicine (251 citations). Nadia Naldi has collaborated with scholars based in Italy, New Zealand and Germany. Frequent co-authors include Roberta Camisa, Andrea Ardizzoni, Beatrice Bortesi, Antonino Musolino, Tauro Maria Neri, Marzia Capelletti, Debora Pezzuolo, Giancarlo Bisagni, Gabriele Missale and Diletta Laccabue. Their work appears in journals such as Cancer, Diagnostic Cytopathology, Lung Cancer, Annals of Oncology and The International Journal of Biological Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.